Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Allergic Conjunctivitis Market, Global Forecast Treated Patients By Countries, Disease Type, Pipeline Drugs, Company Analysis

Published by Renub Research Product code 990233
Published Content info 150 Pages
Delivery time: 1-2 business days
Price
Back to Top
Allergic Conjunctivitis Market, Global Forecast Treated Patients By Countries, Disease Type, Pipeline Drugs, Company Analysis
Published: February 1, 2021 Content info: 150 Pages
Description

Allergic conjunctivitis is common ophthalmic disorder caused by reactions to allergens like pollen or mold spores, dust mites and animal fur. The eyeball has a membrane called conjunctiva which is receptive towards the irritation from allergens.

In July 2020, IACTA Pharmaceuticals & Zhaoke Ophthalmology Pharmaceuticals Ltd has signed an agreement to accelerate the development of drugs called IC265 and IC 270. Earlier they were develop to treat dry eye and later for allergic conjunctivitis.

There are many types of allergic conjunctivitis such as seasonal allergic conjunctivitis is caused by airborne mold spores, spring, late summer, or early fall and disappear during the winter month & perennial allergic conjunctivitis is caused by dust, mites, animal dander, and other non-seasonal allergens.

According to Renub Research, Allergic Conjunctivitis Market was US$ 1.5 Billion in 2020 is expected to grow with a CAGR of 8.81% and reach US$ 2.7 Billion by 2027.

There has been significant increase allergic conjunctivitis due to increase in the use of chemicals and pollution caused by urbanization, industrialization and climate change. The increase in awareness of allergic conjunctivitis is associated its medical treatment & upcoming therapies such as Zerviate, ADX-102, PRT-2761, OTX-DP etc. is one of the factors driving the market.

Many Pharmaceutical companies are trying to develop many new possibilities of treatment for allergic conjunctivitis such as Zerviate, EM-100, ADX-102, PRT-2761, and OTX-DP. For instance, EyeMax LLC's EM-100 is currently in phase 3 of clinical trial, where its effectiveness is being checked in the treatment of ocular itching. Presently, around two third of new treatment options are in phase 2 or 3 of clinical trials.

We have studied by region of North America followed by Europe and Asia-Pacific. The allergic conjunctivitis treatment market in Asia Pacific is expected to grow rapidly, due to having a large population base and increased demand of improved health facilities.

Renub Research report titled "Global Allergic Conjunctivitis Market, Patients, Treated Patients By Countries (India, China, Japan, United States, United Kingdom, France, Germany, Italy, Spain), Disease Type (Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC), Vernal Kerato Conjunctivitis (VKC), Atopic Kerato Conjunctivitis (AKC) And Giant Papillary Conjunctivitis (GPC)), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011) Companies (Santen Pharmaceutical, Alcon (Novartis), Portola Pharmaceuticals, Ocular Therapeutix), Growth Drivers, Challenges" provides a complete analysis of global allergic conjunctivitis market.

Global Allergic Conjunctivitis Market has been analyzed from 9 Major Viewpoints

  • Market - Global Allergic Conjunctivitis
  • Market Share, Disease Type Market Share, Patients Share, Treated Patients Share
  • Market - Country Allergic Conjunctivitis
  • Patients Population - Country Allergic Conjunctivitis
  • Country Allergic Conjunctivitis Treated Patients Population
  • Disease Type - Allergic Conjunctivitis Market
  • Drugs Pipeline - Allergic Conjunctivitis
  • Key Growth factors and Challenges
  • Key Companies Initiatives and Financial Insights

Country - Market breakup from 9 viewpoints

  • India
  • China
  • Japan
  • United States
  • United Kingdom
  • France
  • Germany
  • Italy
  • Spain

Disease - Market Breakup from 4 viewpoints

  • Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)
  • Vernal Kerato Conjunctivitis (VKC)
  • Atopic Kerato Conjunctivitis (AKC)
  • Giant Papillary Conjunctivitis (GPC)

Drugs - Market Breakup from 10 viewpoints

  • Zerviate
  • OTX-DP
  • ADX-102
  • PRT-2761
  • CVXL-0074
  • AK-002
  • Bertilimumab
  • Reproxalap
  • ST-266
  • SYL-116011

All companies has been covered from 3 viewpoints

  • Overviews
  • Recent Developments
  • Revenues

Company Covered

  • Santen Pharmaceutical
  • Alcon (Novartis)
  • Portola Pharmaceuticals
  • Ocular Therapeutix
Table of Contents

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global Allergic Conjunctivitis Market and Patients Analysis

  • 5.1 Market
  • 5.2 Patient Numbers
  • 5.3 Treated Patient Numbers

6. Share Analysis - Global Allergic Conjunctivitis

  • 6.1 Country Market Share
  • 6.2 Patients Population Share
  • 6.3 Treated Patients Population Share
  • 6.4 By Disease Type Share

7. India - Allergic Conjunctivitis Analysis

  • 7.1 Patient Numbers
  • 7.2 Treated Patient Numbers
  • 7.3 Market

8. China - Allergic Conjunctivitis Analysis

  • 8.1 Patient Numbers
  • 8.2 Treated Patient Numbers
  • 8.3 Market

9. Japan - Allergic Conjunctivitis Analysis

  • 9.1 Patient Numbers
  • 9.2 Treated Patient Numbers
  • 9.3 Market

10. United States - Allergic Conjunctivitis Analysis

  • 10.1 Patient Numbers
  • 10.2 Treated Patient Numbers
  • 10.3 Market

11. United Kingdom - Allergic Conjunctivitis Analysis

  • 11.1 Patient Number
  • 11.2 Treated Patient Numbers
  • 11.3 Market

12. France - Allergic Conjunctivitis Analysis

  • 12.1 Patient Numbers
  • 12.2 Treated Patient Numbers
  • 12.3 Market

13. Germany - Allergic Conjunctivitis Analysis

  • 13.1 Patient Numbers
  • 13.2 Treated Patient Numbers
  • 13.3 Market

14. Italy - Allergic Conjunctivitis Analysis

  • 14.1 Patient Numbers
  • 14.2 Treated Patient Numbers
  • 14.3 Market

15. Spain - Allergic Conjunctivitis Analysis

  • 15.1 Patient Numbers
  • 15.2 Treated Patient Numbers
  • 15.3 Market

16. Disease Type - Global Allergic Conjunctivitis Market

  • 16.1 Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)
  • 16.2 Vernal Keratoconjunctivitis (VKC)
  • 16.3 Atopic Keratoconjunctivitis (AKC)
  • 16.4 Giant Papillary Conjunctivitis (GPC)

17. Global Allergic Conjunctivitis Pipeline Drugs

  • 17.1 Zerviate
  • 17.2 OTX-DP (Dexamethasone Insert)
  • 17.3 ADX-102
  • 17.4 PRT2761
  • 17.5 CVXL-0074
  • 17.6 AK-002
  • 17.7 Bertilimumab
  • 17.8 Reproxalap
  • 17.9 ST-266
  • 17.10 SYL-116011

18. Company Analysis

  • 18.1 Santen Pharmaceutical
    • 18.1.1 Company Overview
    • 18.1.2 Recent Developments
    • 18.1.3 Financial Insight
  • 18.2 Alcon Inc. (Novartis)
    • 18.2.1 Company Overview
    • 18.2.2 Recent Developments
    • 18.2.3 Financial Insight
  • 18.3 Portola Pharmaceuticals Inc.
    • 18.3.1 Company Overview
    • 18.3.2 Recent Developments
    • 18.3.3 Financial Insight
  • 18.4 Ocular Therapeutix Inc.
    • 18.4.1 Company Overview
    • 18.4.2 Recent Developments
    • 18.4.3 Financial Insight

List of Figures

  • Figure 2-1: Global - Allergic Conjunctivitis Market (Million US$), 2016 - 2020
  • Figure 2-2: Global - Forecast for Allergic Conjunctivitis Market (Million US$), 2021 - 2027
  • Figure 2-3: Global - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2020
  • Figure 2-4: Global - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 - 2027
  • Figure 2-5: Global - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2020
  • Figure 2-6: Global - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 - 2027
  • Figure 3-1: Global - Allergic Conjunctivitis Market Country Share (Percent), 2016 - 2020
  • Figure 3-2: Global - Forecast for Allergic Conjunctivitis Market Country Share (Percent), 2021 - 2027
  • Figure 3-3: Global - Allergic Conjunctivitis Treated Patients Population Country Share (Percent), 2016 - 2020
  • Figure 3-4: Global - Forecast for Allergic Conjunctivitis Treated Patients Population Country Share (Percent), 2021 - 2027
  • Figure 3-5: Global - Allergic Conjunctivitis Disease Type Market Share (Percent), 2016 - 2020
  • Figure 3-6: Global - Forecast for Allergic Conjunctivitis Disease Type Market Share (Percent), 2021 - 2027
  • Figure 4-1: India - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2020
  • Figure 4-2: India - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 - 2027
  • Figure 4-3: India - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2020
  • Figure 4-4: India - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 - 2027
  • Figure 4-5: India - Allergic Conjunctivitis Market (Million US$), 2016 - 2020
  • Figure 4-6: India - Forecast for Allergic Conjunctivitis Market (Million US$), 2021 - 2027
  • Figure 5-1: China - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2020
  • Figure 5-2: China - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 - 2027
  • Figure 5-3: China - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2020
  • Figure 5-4: China - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 - 2027
  • Figure 5-5: China - Allergic Conjunctivitis Market (Million US$), 2016 - 2020
  • Figure 5-6: China - Forecast for Allergic Conjunctivitis Market (Million US$), 2021 - 2027
  • Figure 6-1: Japan - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2020
  • Figure 6-2: Japan - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 - 2027
  • Figure 6-3: Japan - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2020
  • Figure 6-4: Japan - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025
  • Figure 6-5: Japan - Allergic Conjunctivitis Market (Million US$), 2016 - 2020
  • Figure 6-6: Japan - Forecast for Allergic Conjunctivitis Market (Million US$), 2021 - 2027
  • Figure 7-1: United States - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2020
  • Figure 7-2: United States - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 - 2027
  • Figure 7-3: United States - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2020
  • Figure 7-4: United States - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 - 2027
  • Figure 7-5: United States - Allergic Conjunctivitis Market (Million US$), 2016 - 2020
  • Figure 7-6: United States - Forecast for Allergic Conjunctivitis Market (Million US$), 2021 - 2027
  • Figure 8-1: United Kingdom - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2020
  • Figure 8-2: United Kingdom - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 - 2027
  • Figure 8-3: United Kingdom - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2020
  • Figure 8-4: United Kingdom - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 - 2027
  • Figure 8-5: United Kingdom - Allergic Conjunctivitis Market (Million US$), 2016 - 2020
  • Figure 8-6: United Kingdom - Forecast for Allergic Conjunctivitis Market (Million US$), 2021 - 2027
  • Figure 9-1: France - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2020
  • Figure 9-2: France - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 - 2027
  • Figure 9-3: France - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2020
  • Figure 9-4: France - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 - 2027
  • Figure 9-5: France - Allergic Conjunctivitis Market (Million US$), 2016 - 2020
  • Figure 9-6: France - Forecast for Allergic Conjunctivitis Market (Million US$), 2021 - 2027
  • Figure 10-1: Germany - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2020
  • Figure 10-2: Germany - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 - 2027
  • Figure 10-3: Germany - Allergic Conjunctivitis Patient Treated Numbers (Million), 2016 - 2020
  • Figure 10-4: Germany - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 - 2027
  • Figure 10-5: Germany - Allergic Conjunctivitis Market (Million US$), 2016 - 2020
  • Figure 10-6: Germany - Forecast for Allergic Conjunctivitis Market (Million US$), 2021 - 2027
  • Figure 11-1: Italy - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2020
  • Figure 11-2: Italy - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 - 2027
  • Figure 11-3: Italy - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2020
  • Figure 11-4: Italy - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 - 2027
  • Figure 11-5: Italy - Allergic Conjunctivitis Market (Million US$), 2016 - 2020
  • Figure 11-6: Italy - Forecast for Allergic Conjunctivitis Market (Million US$), 2021 - 2027
  • Figure 12-1: Spain - Allergic Conjunctivitis Patient Numbers (Million), 2016 - 2020
  • Figure 12-2: Spain - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2021 - 2027
  • Figure 12-3: Spain - Allergic Conjunctivitis Treated Patient Numbers (Million), 2016 - 2020
  • Figure 12-4: Spain - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2021 - 2027
  • Figure 12-5: Spain - Allergic Conjunctivitis Market (Million US$), 2016 - 2020
  • Figure 12-6: Spain - Forecast for Allergic Conjunctivitis Market (Million US$), 2021 - 2027
  • Figure 13-1: Global - Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2016 - 2020
  • Figure 13-2: Global - Forecast for Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2021 - 2027
  • Figure 13-3: Global - Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2016 - 2020
  • Figure 13-4: Global - Forecast for Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2021 - 2027
  • Figure 13-5: Global - Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2016 - 2020
  • Figure 13-6: Global - Forecast for Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2021 - 2027
  • Figure 13-7: Global - Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2016 - 2020
  • Figure 13-8: Global - Forecast for Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2021 - 2027
  • Figure 14-1: Allergic Conjunctivitis Pipe Line Drug - Zerviate Status (2018)
  • Figure 14-2: Allergic Conjunctivitis Pipe Line Drug - OTX-DP (Dexamethasone Insert) Status (2018)
  • Figure 14-3: Allergic Conjunctivitis Pipe Line Drug - ADX-102 Status (2018)
  • Figure 14-4: Allergic Conjunctivitis Pipe Line Drug - PRT-2761Status (2018)
  • Figure 14-5: Allergic Conjunctivitis Pipe Line Drug - CVXL-0074 Status (2018)
  • Figure 14-6: Allergic Conjunctivitis Pipe Line Drug - AK-002 Status (2018)
  • Figure 14-7: Allergic Conjunctivitis Pipe Line Drug - Bertilimumab Status (2018)
  • Figure 14-8: Allergic Conjunctivitis Pipe Line Drug - Reproxalap Status (2018)
  • Figure 14-9: Allergic Conjunctivitis Pipe Line Drug - ST-266 Status (2018)
  • Figure 14-10: Allergic Conjunctivitis Pipe Line Drug - SYL-116011 Status (2018)
  • Figure 17-1: Santen Pharmaceutical - Global Revenue (Million US$), 2016 - 2020
  • Figure 17-2: Santen Pharmaceutical - Forecast for Global Revenue (Million US$), 2021 - 2027
  • Figure 18-1: Alcon (Novartis) - Global Revenue (Million US$), 2016 - 2020
  • Figure 18-2: Alcon (Novartis) - Forecast for Global Revenue (Million US$), 2021 - 2027
  • Figure 19-1: Portola Pharmaceuticals - Global Revenue (Thousand US$), 2016 - 2020
  • Figure 19-2: Portola Pharmaceuticals - Forecast for Global Revenue (Thousand US$), 2021 - 2027
  • Figure 20-1: Ocular Therapeutix - Global Revenue (Thousand US$), 2016 - 2020
  • Figure 20-2: Ocular Therapeutix - Forecast for Global Revenue (Thousand US$), 2021 - 2027
  • Figure 21-1: Novartis - Global Revenue (Million US$), 2016 - 2020
  • Figure 21-2: Novartis - Forecast for Global Revenue (Thousand US$), 2021 - 2027

List of Tables

  • Table 3-1: Global - Allergic Conjunctivitis Patients Population Country Share (Percent), 2016 - 2020
  • Table 3-2: Global - Forecast for Allergic Conjunctivitis Patients Population Country Share (Percent), 2021 - 2027
Back to Top